PROPANC BIOPHARMA, INC. Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger
PROPANC BIOPHARMA, INC. (PPCB) reported Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger of 4.99% for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger · last filed 2025-05-15
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for the quarter ending 2024-09-30 was 4.99%, a 0.00% change year-over-year.
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for the quarter ending 2023-09-30 was 4.99%, a 0.00% change year-over-year.
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for the quarter ending 2022-09-30 was 4.99%.
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for the quarter ending 2020-09-30 was 4.99%, a 0.00% change year-over-year.
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for fiscal 2024 was 4.99%, a 0.00% change from fiscal 2023.
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for fiscal 2023 was 4.99%, a 0.00% change from fiscal 2022.
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for fiscal 2022 was 4.99%.
- PROPANC BIOPHARMA, INC. debt instrument, convertible, threshold percentage of stock price trigger for fiscal 2020 was 4.99%, a 0.00% change from fiscal 2019.
| Period end | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger 1 month | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger 3 month | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger 6 month | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger 9 month | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | 4.99% 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | 4.99% 10-Q · filed 2025-02-14 | ||||
| 2024-09-30 | 4.99% 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | 4.99% 10-K · filed 2024-09-30 | ||||
| 2024-03-31 | 4.99% 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | 4.99% 10-Q · filed 2024-02-20 | ||||
| 2023-09-30 | 4.99% 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | 4.99% 10-K · filed 2023-09-28 | ||||
| 2023-03-31 | 4.99% 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 4.99% 10-Q · filed 2023-02-10 | ||||
| 2022-09-30 | 4.99% 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 4.99% 10-K · filed 2022-09-28 | ||||
| 2022-03-31 | 4.99% 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | 4.99% 10-Q · filed 2022-02-14 | ||||
| 2021-06-30 | 4.99% 10-Q · filed 2021-11-12 | ||||
| 2021-03-31 | 4.99% 10-Q · filed 2021-05-14 | ||||
| 2020-12-31 | 4.99% 10-Q · filed 2021-02-12 | ||||
| 2020-09-30 | 4.99% 10-Q · filed 2020-11-16 | ||||
| 2020-06-30 | 4.99% 10-K · filed 2020-10-01 | ||||
| 2020-03-31 | 4.99% 10-Q · filed 2020-05-15 | ||||
| 2019-12-31 | 4.99% 10-Q · filed 2020-02-14 | ||||
| 2019-09-30 | 4.99% 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | 4.99% 10-K · filed 2019-10-15 | ||||
| 2019-03-31 | 4.99% 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | 4.99% 10-Q · filed 2019-02-14 | ||||
| 2018-09-30 | 4.99% 10-Q · filed 2018-11-13 | ||||
| 2016-03-31 | 22.50% 10-Q · filed 2016-05-16 | ||||
| 2015-05-19 | 55.00% 10-Q · filed 2016-05-16 | ||||
| 2014-12-31 | 12.00% 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |